Revelation Biosciences, Inc. (REVB)
|Net Income (ttm)||n/a|
|Day's Range||2.58 - 3.30|
|52-Week Range||2.58 - 11.29|
Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal co... [Read more...]
SAN DIEGO, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immu...
REPEAT -- Revelation Biosciences Inc. Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS...
-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed-
Petra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Bio...
-The Definitive Proxy Statement Has Been Filed with The Securities and Exchange Commission-
Revelation Biosciences Inc is joining Petra Acquisition Inc (NASDAQ: PAIC) to create a NASDAQ-listed company with an enterprise value of $128 million. The merger is expected to close in Q4 2021, and th...
New York, NY, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Petra Acquisition, Inc. (NASDAQ: PAICU) (the “Company”) announced today that separate trading of its shares of common stock and warrants underlying the Co...
New York, NY, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Petra Acquisition, Inc. (Nasdaq: PAICU) (the “Company”) is a blank check company organized for the purpose of effecting a merger, share exchange, asset ac...
Bank Deepens Presence in the Region and Welcomes New Executives and Directors Bank Deepens Presence in the Region and Welcomes New Executives and Directors